Identification of 28 novel mutations in the Bardet–Biedl syndrome genes: the burden of private mutations in an extensively heterogeneous disease
✍ Scribed by Jean Muller; C. Stoetzel; M. C. Vincent; C. C. Leitch; V. Laurier; J. M. Danse; S. Hellé; V. Marion; V. Bennouna-Greene; S. Vicaire; A. Megarbane; J. Kaplan; V. Drouin-Garraud; M. Hamdani; S. Sigaudy; C. Francannet; J. Roume; P. Bitoun; A. Goldenberg; N. Philip; S. Odent; J. Green; M. Cossée; E. E. Davis; N. Katsanis; D. Bonneau; A. Verloes; O. Poch; J. L. Mandel; H. Dollfus
- Publisher
- Springer
- Year
- 2010
- Tongue
- English
- Weight
- 487 KB
- Volume
- 127
- Category
- Article
- ISSN
- 0340-6717
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Hunter syndrome (Mucopolysaccharidosis type II, MPS2) is an X-linked recessively inherited disease caused by a deficiency of iduronate 2 sulfatase (IDS). In this study, we investigated mutations of the IDS gene in 25 Korean Hunter syndrome patients. We identified 20 mutations, of which 13 mutations
## Communicated by Darwin Prockop Mutations in the human fibrillin 1 gene (FBN1) cause the Marfan syndrome (MFS), an autosomal dominant connective tissue disorder. Knowledge about FBN1 mutations is important for early diagnosis, management, and genetic counseling. However, mutation detection in FB
Mutation analysis of the N-acetylgalactosamine-6-sulfate sulfatase gene was performed in a group of 35 patients with mucopolysaccharidosis type IVA from 33 families, mainly of European origin. By nonradioactive SSCP screening, 35 different gene mutations were identified, 31 of them novel. Together t